Total Funding
66
70
Total FundingSeries C raised
Growth Score
-3 pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
38921
SphingoTec develops innovative biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions.
- Jörg Menten: CEOPast Role: Sphingotec GmbH, CCO and Managing Director
- Andreas Bergmann: Founder & CSOPast Role: Sphingotec GmbH, CEO
About the Company
SphingoTec is a biomaker company that develops and markets in vitro diagnostic solutions for novel and proprietary blood-based protein biomarkers. They also develop microtiter plates, which are a standard tool in analytical research and diagnostic testing laboratories. They develop biomakers to address diagnostically underserved critical care
conditions such as acute kidney injury, sepsis, and acute heart failure.
